News

Greg Peton Appointed to Boost Pivot Bio's Sales Strategy

Greg Peton Appointed to Boost Pivot Bio's Sales Strategy

Greg Peton Appointed Regional Sales Leader at Pivot Bio

Pivot Bio, a leading player in agricultural technology, has appointed Greg Peton as the regional sales leader for its coastal region. In this pivotal role, Peton will be at the forefront of sales efforts across a vast territory, including territories like Texas, the Carolinas, and the Northeast, up to areas such as New York and Pennsylvania. His mission is to support farmers and retail partners by facilitating access to Pivot Bio's award-winning, patented crop nutrition technologies.

Empowering Farmers Through Innovative Technologies

Pivot Bio offers groundbreaking products such as the third-generation nitrogen product for corn, PROVEN G3, and its new cotton solution, CERT-N. The company has seen these products gain adoption over more than 15 million acres in recent years, highlighting robust farmer demand and exceptional field performance.

Experience and Leadership Background

With a wealth of experience spanning decades in agricultural sales and leadership, Greg Peton understands the nuances of crop nutrition and the challenges farmers face. Joining Pivot Bio in 2020 as a national account manager, he quickly established strong relationships with some of the largest growers across the United States. His ability to connect and engage with farmers has solidified his reputation as a trusted leader in the industry.

Valuable Insights from Industry Experts

Chris Turner, the chief commercial officer at Pivot Bio, expressed confidence in Peton's capabilities, stating that he knows what it takes to help farmers succeed and understands the realities from the ground up. Additionally, Daryl Allen, the vice president of sales, emphasized Peton's operational strengths, showcasing his ability to navigate complex operations effectively.

Career Journey Before Pivot Bio

Prior to his tenure at Pivot Bio, Peton held prominent roles at DuPont Pioneer, Rizobacter, and United Farmers Cooperative, where he served as chief sales and marketing officer. His early life on a diversified grain, dairy, and livestock farm in northwest Iowa shaped his insights into the agricultural sector.

About Pivot Bio

Pivot Bio, renowned for its innovative solutions in agtech, provides farmers with patented technologies that leverage nature's power for enhanced crop nutrition. Their commitment is to ensure reliable food production amidst growing challenges. The company's products are primarily available in North America and will soon expand into Brazil. Pivot Bio's innovations have garnered multiple recognitions, including three accolades from Time magazine as one of the best inventions, and a spot on Fast Company’s World Changing Ideas list.

Commitment to Sustainable Agriculture

As agriculture faces increasing volatility, the advancements from Pivot Bio represent a crucial development in sustaining agricultural productivity and addressing food security challenges globally. With its cutting-edge solutions, Pivot Bio is not only transforming agricultural practices but also contributing to the broader mission of environmental sustainability.

Frequently Asked Questions

What is the role of Greg Peton at Pivot Bio?

Greg Peton has been appointed the regional sales leader for Pivot Bio's coastal region, focusing on supporting farmers with innovative crop nutrition technologies.

What innovative products does Pivot Bio offer?

Pivot Bio offers two key products: PROVEN G3, a third-generation nitrogen product for corn, and CERT-N, a new cotton solution, both aimed at enhancing crop performance.

What background does Greg Peton have in agriculture?

Greg Peton has decades of experience in agricultural sales and leadership, with previous roles at DuPont Pioneer and Rizobacter among others.

What is the mission of Pivot Bio?

Pivot Bio’s mission is to deliver reliable and sustainable crop nutrition solutions that meet the changing demands of the agriculture industry.

Where are Pivot Bio’s products available?

Currently, Pivot Bio's products are available in North America and are set to expand into Brazil soon.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Stora Enso's Major Cross-Border Demerger Plan Unfolds

Updated Category News Views 88

A Grand Meeting with Serious Stakes The Board at Stora Enso Oyj is calling for an Extraordinary General Meeting (EGM) to tackle something massive—a cross-border partial demerger. Scheduled for December 15, 2026, this big pow-wow will take place in Helsinki, Finland. There’s a boatload of logistics in play, not least because it’s intended to split off their Swedish...

Continue Reading
Atrium's Heart Therapies: ATR 1072's Promising Data

Updated Category News Views 21

Atrium Therapeutics Strikes a Chord with New Data Tuning into the heartbeats of breakthrough developments, Atrium Therapeutics dropped some fresh, nonclinical insights about their latest contender, ATR 1072. This wasn't just any ordinary announcement; it's like when the market hears whispers of a Fed rate adjustment. The venue? The American Heart Association's 2026...

Continue Reading
ADC Therapeutics Preps Financial Results Release

Updated Category News Views 0

ADC Therapeutics: Eyes on the Financial Prize So here we are, folks—ADC Therapeutics is blitzing the stage and gearing up to spill the beans on their third-quarter saga come November 9, 2026. Who needs a crystal ball when you've got a press release to dissect every number and nuance? Anticipating the Numbers: What's at Stake? ADC Therapeutics has been riding the wave of...

Continue Reading
Isinwheel's 2027 E-Mobility Pitch: Beyond Resolutions

Updated Category News Views 163

Embracing the E-Mobility Shift Here we are at the tail end of 2026, and isinwheel is riding high on the wave of New Year resolutions with their hefty e-mobility lineup. It's not just about buying the gear—it's about tackling our reliance on gas-guzzlers with electric scooters and bikes as our trusty steeds. "Reduce car trips? More greenery in your commute? These aren't...

Continue Reading
Wujiang Celebrates 90 Years of Fei Xiaotong's Legacy

Updated Category News Views 118

If you thought anniversaries were just about looking back, think again! In Wujiang, November 1st was all about forging ahead. Scholars and local officials weren't just reminiscing about Fei Xiaotong's landmark field study at Jiangcun 90 years ago; they were strategizing how to apply the sociologist's insights to today's economic and community challenges. Marking a Legacy...

Continue Reading
German Court Backs Usmanov in Legal Standoff with EU

Updated Category News Views 44

Usmanov Scores a Win in German Courts The courtroom dramas play out yet again, and this time the spotlight's on Alisher Usmanov versus the European Union Council. It's a scene rich in bureaucratic fireworks, where Germany's Federal Court of Justice shined a beam of clarity amidst all that legal fog. They call it a 'landmark ruling'—a voice of reason brushing aside the...

Continue Reading
Fresenius, WuXi Biologics Blaze New Biosimilars Trail

Updated Category News Views 97

Fresenius Bets Big on Biopharma with WuXi Partnership A deal inked by Fresenius and WuXi Biologics is stirring up the biosimilars pot, aiming to widen Fresenius' grip on the market tenfold. We're not talking small potatoes here; we're talking up to 66 biosimilar molecules against a hefty backdrop of more than €370 billion in originator sales. It's as if they've said,...

Continue Reading
Sinopec Unveils Biodiversity Report at COP17

Updated Category News Views 47

Sinopec's First Step on the Global Biodiversity Stage Seems like Sinopec (HKG: 0386) has decided to toss its hat into the biodiversity conservation ring. At COP17 in Armenia, they released their inaugural Global Biodiversity Conservation Report—an event that marks more than just a company selling oil and gas. Now, they're talking wildlife and ecologies. Is that irony,...

Continue Reading
Bahrain's USD 3.89 Billion Investment Surge in 2026

Updated Category News Views 228

Bahrain's Bold Moves to Woo Global Investment Bahrain's never been one to tiptoe around, huh? With a whopping USD 3.89 billion on the line, the Kingdom's flashing its neon sign to investors: "Open for Business!" These Golden License projects aren't just a few shiny new ventures — they're bridging aviation logistics, real estate, and the tech sector. Talk about ambition....

Continue Reading
Muyang Group's High-Stakes Legal Battle Over Corporate Sabotage

Updated Category News Views 108

Decades of Corporate Drama Unfold in Court A pesky legal storm is brewing from the heart of Yangzhou, China, as Jiangsu Muyang Group battles former execs in a lawsuit that reeks of corporate intrigue. You can't make this stuff up—downright Shakespearean treachery unfolding at a feed machinery powerhouse! Muyang's courtroom escapades haven't exactly flown under the...

Continue Reading

Top 5 Most Recently Viewed Articles

Talen Energy's Upcoming Earnings Call Set for Early August

Updated Category News Views 222

Talen Energy's Financial Call Announcement Talen Energy Corporation is gearing up to share its financial results for the second quarter of 2025. The announcement is scheduled for Thursday, August 7, 2025, before the markets open. This event will mark an important moment for the company as it briefs investors on its fiscal health and operational achievements. Details of...

Continue Reading
Parsable Honored with Global Leadership Award for Innovation

Updated Category News Views 144

Recognizing Innovation in Manufacturing Technology Parsable has recently made headlines by being honored with a prestigious award that recognizes its revolutionary contributions to manufacturing technology. Their mobile-first SaaS platform has significantly changed how manufacturing processes are digitized, providing real-time data analytics and tailored solutions that...

Continue Reading
20 Years of Investment: The Growth of Charles Schwab SCHW

Updated Category News Views 390

The Growth of Charles Schwab Over 20 Years Over the past two decades, Charles Schwab (SCHW) has shown exceptional performance in the investment arena, consistently outperforming market returns. With an annualized return of 9.89%, it has surpassed the market by 1.67% each year, showcasing its effective growth strategy. Currently, the company enjoys a remarkable market...

Continue Reading
Superior Energy Services Plans Major Senior Secured Notes Sale

Updated Category News Views 153

Superior Energy Services Announces Senior Secured Notes Offering Superior Energy Services, Inc. has recently made headlines with its announcement regarding a significant financial move. The company intends to offer $600 million in aggregate principal amount of Senior Secured Notes through its wholly-owned subsidiary, SESI, L.L.C. This offering is subject to favorable...

Continue Reading
Saudi Stocks Experience Modest Gains Amid Mixed Performances

Updated Category News Views 187

Saudi Stock Market Overview On a recent trading day, Saudi stocks experienced a modest uptick, reflecting a mixed performance across various sectors. The Tadawul All Share Index, the benchmark for the Saudi Arabian stock market, rose by 0.07%. This increase is attributed to gains in critical sectors that underlined the trading activity. Sector Performance The financial...

Continue Reading